SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-037136
Filing Date
2023-03-27
Accepted
2023-03-27 16:26:59
Documents
15
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2310400d1_10ka.htm   iXBRL 10-K/A 73712
2 EXHIBIT 4.11 tm2310400d1_ex4-11.htm EX-4.11 21043
3 EXHIBIT 31.1 tm2310400d1_ex31-1.htm EX-31.1 3058
4 EXHIBIT 31.2 tm2310400d1_ex31-2.htm EX-31.2 3128
  Complete submission text file 0001104659-23-037136.txt   328038

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA edsa-20220930.xsd EX-101.SCH 3021
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20220930_lab.xml EX-101.LAB 36509
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20220930_pre.xml EX-101.PRE 23990
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2310400d1_10ka_htm.xml XML 5610
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-37619 | Film No.: 23764820
SIC: 2834 Pharmaceutical Preparations